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Injection of the seaweed toxin kainic acid (KA) in rats induces a severe status epilepticus initiating
complex neuropathological changes in limbic brain areas and subsequently spontaneous recurrent
seizures. Although neuropathological changes have been intensively investigated in the hippocampus
proper and the dentate gyrus in various seizure models, much less is known about changes in para-
hippocampal areas. We now established telemetric EEG recordings combined with continuous video
monitoring to characterize the development of spontaneous seizures after KA-induced status epilepticus,
and investigated associated neurodegenerative changes, astrocyte and microglia proliferation in the
subiculum and other parahippocampal brain areas. The onset of spontaneous seizures was heteroge-
neous, with an average latency of 15  1.4 days (range 3e36 days) to the initial status epilepticus. The
frequency of late spontaneous seizures was higher in rats in which the initial status epilepticus was
recurrent after its interruption with diazepam compared to rats in which this treatment was more
efﬁcient. Seizure-induced neuropathological changes were assessed in the subiculum by losses in
NeuN-positive neurons and by Fluoro-Jade C staining of degenerating neurons. Neuronal loss was already
prominent 24 h after KA injection and only modestly progressed at the later intervals. It was most severe
in the proximal subiculum and in layer III of the medial entorhinal cortex and distinct Fluoro-Jade C
labeling was observed there in 75% of rats even after 3 months. Glutamatergic neurons, labeled by in situ
hybridization for the vesicular glutamate transporter 1 followed a similar pattern of cell losses, except for
the medial entorhinal cortex and the proximal subiculum that appeared more vulnerable. Glutamate
decarboxylase65 (GAD65) mRNA expressing neurons were generally less vulnerable than glutamate
neurons. Reactive astrocytes and microglia were present after 24 h, however, became prominent only
after 8 days and remained high after 30 days. In the proximal subiculum, parasubiculum and entorhinal
cortex the number of microglia cells was highest after 30 days. Although numbers of reactive astrocytes
and microglia were reduced again after 3 months, they were still present in most rats. The time course of
astrocyte and microglia proliferation parallels that of epileptogenesis.
 2012 Elsevier Ltd. Open access under CC BY-NC-ND license.1. Introduction
A single episode of sustained status epilepticus (SE) can be the
cause for mesial temporal lobe epilepsy (TLE), both in patients and
in experimental animals (Lothman and Bertram, 1993). In patients,Jade C; GAD65 and GAD67,
ary acidic protein; KA, kainic
epilepticus; Sub, subiculum;
ate transporter 1.
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Y-NC-ND license.a seizure-free period, often lasting for years, follows the initial SE
and precedes the occurrence of the ﬁrst spontaneous seizures and
thus manifestation of epilepsy (Falconer et al., 1964; Sagar and
Oxbury, 1987). It is assumed that during this “silent period”
neuropathological changes developmaking the brain susceptible to
recurrent seizures. In rats, electrical stimulation or injections of
toxins like kainic acid (KA) or pilocarpine are widely used as animal
models to induce an SE and associated changes. For investigating
neuropathological changes leading to spontaneous seizures and
thus manifestation of epilepsy, the assessment of the onset of
spontaneous seizures is crucial. So far, chronic electrographic
recordings throughmultiple permanent brain electrodes have been
used in epilepsy models and varying results have been obtained for
the onset of acute seizures in different animal models (Bertram
et al., 1990; Gofﬁn et al., 2007; Pitkanen et al., 2002; Vezzani
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that the animals have to be permanently connected to the electrode
cables and therefore are not accessible to more detailed behavioral
investigations. We now established telemetric EEG recordings
combined with continuous video monitoring in freely moving rats
and characterized the development of spontaneous seizures after
intraperitoneal injection of KA.
Neuropathological changes associated with KA-induced SE have
been well characterized in the dentate gyrus and hippocampus
proper. They include fast development of brain edema, local
bleeding (Sperk et al., 1983), break down of the bloodebrain barrier
(Lassmann et al., 1984; Seiffert et al., 2004; Sokrab et al., 1989; van
Vliet et al., 2007) followed by severe neuronal damage in sectors
CA3 and CA1 of the hippocampus proper, the dentate gyrus and
associated limbic brain areas such as the amygdala, the piriform
and entorhinal cortices and the thalamus (Ben-Ari et al., 1980; Du
et al., 1995; Nadler, 1981; Schwob et al., 1980; Sperk et al., 1983).
In recent years a crucial role of the subiculum and of other para-
hippocampal regions was recognized in epileptogenesis (Palma
et al., 2006; Wozny et al., 2005a,b) and network hyperexcitability
was demonstrated in the subiculum in animal models and in
human TLE (de Guzman et al., 2006; Huberfeld et al., 2011; Knopp
et al., 2005). Interestingly, in human TLE the subiculum remains
largely preserved (Alonso-Nanclares et al., 2011; Bratz, 1899;
Furtinger et al., 2001) whereas parvalbumin and glutamate decar-
boxylase 65 (GAD65) positive interneurons of the subiculum are
lost after pilocarpine- and KA-induced seizures (Drexel et al., 2011;
Knopp et al., 2008). In the present study, we therefore investigated
neurodegeneration and changes in the expression of reactive
astrocytes and microglia in the proximal and distal parts of the
subiculum, the pre- and parasubiculum and the entorhinal cortex.
2. Experimental procedures
2.1. Animals
Male SpragueeDawley rats (210e260 g, Forschungsinstitut für Versuch-
stierzucht, Himberg, Austria) were housed in individually ventilated cages at
a temperature of 22e23 C, a relative humidity of 50e60%, and a 12 h light/dark
cycle. They had free access to food and water. All animal experiments were carried
out in accordance with the U.K. Animals (Scientiﬁc Procedures) Act, 1986 and
associated guidelines, the European Communities Council Directive of 24 November
1986 (86/609/EEC). They were approved by the Committee for Animal Protection of
the Austrian Ministry of Science. Care was taken to minimize suffering of the rats.
Seventy-ﬁve rats with KA-induced seizures and 33 controls were included in the
study (in total 108 rats). Thirty-ﬁve of the KA treated rats and 14 controls were
monitored by EEG-telemetry and video recording.
2.2. Implantation of EEG-transmitters
For implantation of EEG-transmitters we followed a protocol established by
Pitsch et al. (2007) used in mice. Rats were given analgesic treatment (5 mg/kg
carprofen s.c., Rimadyl, Pﬁzer, USA) 60min prior to surgery. Anesthesia was initiated
by i.p. injection of 60 mg/kg thiopental (Sandoz, Kundl, Austria) and was maintained
by application of sevoﬂurane (Sevorane, Abbott, Vienna, Austria) through a veteri-
nary anesthesia mask (VIP 3000, Matrx by Midmark, USA).
The skin on the head and the back between the shoulders was shaved and
swabbed with 70% ethanol. After placing the rat in the stereotactic apparatus (David
Kopf Instruments, Tujunga, USA), its eyes were moistened with 0.9% NaCl and
xylocaine-spray (lidocaine-hydrochloride, AstraZeneca, Vienna, Austria) was
applied locally at the anticipated incision sites. An incision was set at the back
between the shoulders and the biopotential transmitter (TA10EA-F20, Data Sciences
International, Arden Hills, USA) was inserted creating a subcutaneous pocket. Then,
a second incision was cut rostrocaudally in the skin over the skull and the perios-
teum was removed. Two holes were drilled into the skull (4.0 mm posterior and
3.0 mm left and right to the bregma) and the electrode leads were attached to the
skull bone with stainless steel screws (M1*2, Hummer und Rieß GmbH, Nürnberg,
Germany) in an epidural position and ﬁxed with dental cement (Paladur e Heraeus
Kulzer, Henry Schein, Austria). Incisions on skull and back were closed and the rats
were placed under an infrared lamp until recovery of consciousness. The rats were
given additional pain relief (5 mg/kg carprofen) once a day for three days and were
allowed to recover for one week.2.3. Kainic acid injection
In total, 45 transmitter-implanted rats were injected with 10 mg/kg KA each
(5 mg/ml in saline, pH 7.0, i.p.) and 14 rats with saline. Two rats did not respond
and 8 died. In 14 rats the electrodes became loose after 3e8 weeks. Thus, 19 KA-
injected rats (stage 3 and 4) were monitored (EEG- and video recordings) for the
entire three months. Rats that lost their electrodes earlier than 8 weeks after KA,
were used for determining the onset of spontaneous seizures and, when reason-
able, for neuropathological evaluation. For investigating neurodegeneration and
gliosis at earlier intervals we treated in addition 52 rats with KA without moni-
toring EEG.
2.4. Evaluation of status epilepticus
Upon injection of KA, development of acute seizures and SE were monitored for
at least 3 h and rated as described previously (Sperk et al., 1983). Brieﬂy, a 5-stage
rating scale based on behavioral changes was used. Rats without any obvious
behavioral changes were rated as stage 0; rats exposing onlywet dog shakes as stage
1; rats with chewing, head bobbing and forelimb cloni as stage 2; rats with gener-
alized seizures and rearing as stage 3; rats with generalized seizures, rearing and
falling (loss of postural tone) as stage 4, and rats that died during SE were rated as
stage 5. To reducemortality and severity of the neuropathological changes, ratswere
treated with diazepam (10 mg/kg i.p., Gewacalm, Nycomed Austria GmbH, Linz,
Austria) 2 h after the ﬁrst generalized seizure.
2.5. Telemetric EEG and video monitoring
Transmitter-implanted rats were single-housed in individually ventilated cages
(l: 34 cm, w: 27 cm, h: 20 cm) and EEGs were recorded using an EEG-telemetry
system (Dataquest A.R.T. Data Acquisition 4.0 for telemetry systems, Data Sciences
International, Arden Hills, USA) with concomitant video monitoring for three days
before and up to three months after KA injection. Transmitter emitted EEG signals
were recorded by receiver plates located below the cages, transferred to a PC system
by a data exchange matrix, and saved to an external hard disk drive. Axis 221
network cameras (Axis communications AB, Lund, Sweden) were used for video
monitoring. During darkness, illumination was established using an infrared spot-
light (Conrad Electronic GmbH, Wels, Austria). The video cameras were synchro-
nized with the telemetric EEG system.
EEG activity was recorded at a sampling rate of 1000 Hz with no a priori ﬁlter
cut-off. For detecting spontaneous recurrent seizures EEG traces were evaluated by
two independent observers. Seizures were deﬁned as EEG segments with contin-
uous synchronous high-frequency and high-amplitude oscillations (>2 baseline
amplitude) with a minimum duration of 10 s. Additionally, prolonged periods of
increased EEG activity were also screened for the presence of a period of post-ictal
depression of the EEG signal (below baseline EEG activity). Duration of single
spontaneous seizures was determined in the EEG trace. Seizures identiﬁed by EEG
were then investigated for a behavioral correlate by inspecting the synchronized
video recordings and were classiﬁed as subclinical (EEG seizures only) or clinical
seizures (EEG and motor seizures).
For automatic detection of spike events during SE, raw EEG traces were ﬁltered
(high-pass at 10 Hz) to eliminate movement-related artifacts. For each rat, an
artifact-free 10 min period of awake EEG was used as baseline EEG. For automated
spike detection, threshold amplitudewas set 5 standard deviations above and below
the mean of the baseline signal and each positive or negative baseline crossing was
counted (SIGVIEW 2.4, SignalLab, http://www.sigview.com).
2.6. Preparation of tissue and of sections
For subsequent immunohistochemistry and Nissl staining, rats were killed
either 24 h (n ¼ 9), 8 days (n ¼ 9), 1 month (n ¼ 13), or 3 months (n ¼ 15) after the
initial KA-induced SE. They were deeply anesthetized by i.p. injection of thiopental
(150mg/kg, Sandoz GmbH, Kundl, Austria) and subsequently perfused transcardially
with phosphate buffered saline pH 7.4 (40 ml) followed by 100 ml of ice-cold 4%
paraformaldehyde in 50 mM phosphate buffer, pH 7.4. Brains were carefully
removed from the skulls and post-ﬁxed in ice-cold paraformaldehyde for 90 min,
immersed in ice-cold 20% sucrose in 50 mM phosphate buffer for 24 h, snap-frozen
in 70 C isopentane (Merck, Darmstadt, Germany, 3 min) and stored at 70 C.
Horizontal 30 mm sections were cut on a cryostat-microtome (Carl Zeiss AG, Vienna,
Austria), collected in 50 mM Trisebuffered saline (TBS, pH 7.2) containing 0.1% NaN3
(Merck, Darmstadt, Germany) and stored at 4 C. Nissl staining (cresyl violet) was
performed in every 11th section for collecting series of slides at the same anatomical
level from the different rats for subsequent concomitant histochemical labeling.
Brains from 20 saline-injected rats were processed accordingly and used as controls
for immunohistochemistry.
For in situ hybridization, additional rats were killed by exposure to CO2 24 h
(n ¼ 5), 8 days (n ¼ 6), 1 month (n ¼ 5) and 3 months (n ¼ 13) after KA-induced SE.
Thirteen saline-injected rats were used as controls. After exposure to CO2, rats were
decapitated and the brains were quickly removed and snap-frozen in isopentane
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at 70 C.
2.7. Fluoro-Jade C labeling
To identify degenerating neurons, we performed Fluoro Jade C staining (FJ-C,
Chemicon, USA) according to Schmued et al. (2005).
2.8. Indirect immunohistochemistry
Immunohistochemistry for neuron-speciﬁc nuclear protein (NeuN) was per-
formed on free-ﬂoating sections. Sections were incubated in 50 mM Trisebuffered
saline with 0.4% Triton X-100 (TBS-Triton, Sigma, St. Louis, USA) for 30 min and
then in blocking serum (10% normal rabbit serum in TBS-Triton, 90 min). They were
incubated over night at room temperature with a monoclonal antibody for NeuN
(1:10,000; MAB 377, Chemicon, USA) in 10% blocking serum. After rinsing in TBS-
Triton (3 times, 5 min), the sections were incubated with a horseradish
peroxidase-coupled secondary antibody (P260 rabbit anti mouse antibody, DAKO,
Glostrup, Denmark) 1:200 in 10% blocking serum/TBS-Triton (150 min, room
temperature). After washing in TBS, the sections were reacted with 0.001% of dia-
minobenzidine tetrahydrochloride dihydrate (DAB, Fluka, Sigma-Aldrich Handels
GmbH, Vienna, Austria) in TBS-buffer containing 0.005% H2O2 (30%, Merck, Darm-
stadt, Germany). They were mounted on gelatin-coated glass slides in 55% ethanol,
allowed to dry overnight in ethanol, cleared in butyl acetate and cover-slipped with
Eukitt mounting medium (O. Kindler GmbH, Freiburg, Germany). Omission of the
primary antisera eliminated all speciﬁc immunoreactivity.
2.9. Ox-42 immunohistochemistry by the avidin-biotin method
To label type 3 complement receptor CR3 (Ox-42) of reactive microglia the ABC-
immunohistochemistry was performed in free-ﬂoating sections. They were incu-
bated in 0.4% Triton in TBS (TBS-Triton) for 30 min and then in blocking serum (10%
normal horse serum in TBS-Triton; 90 min). The sections were then incubated with
primary antibody (MCA275G, Serotec, UK, 1:30,000 in 10% blocking serumwith 0.1%
NaN3) over night and then rinsed in TBS-Triton (three times for 5 min). They were
then incubated with the biotinylated secondary antibody (1:200 in 10% blocking
serum, Vectastain ABC-KIT, Vector Laboratories, Burlingame, USA) for 30 min, rinsed
with TBS-Triton (5 min) and incubated with the avidin-biotin peroxidase complex
(1:100 in 10% blocking serum; Vectastain ABC-KIT, Vector Laboratories, Burlingame,
USA) for 30 min. After rinsing the sections in TBS-buffer, they were reacted with
0.001% of DAB and 0.005% of H2O2 in TBS-buffer for 4min and transferred toTBS. The
sections weremounted on gelatin-coated glass slides and cover-slipped as described
above.
2.10. Immunoﬂuorescence for glial ﬁbrillary acidic protein (GFAP)
Native and reactive astrocytes were labeled for glial ﬁbrillary acidic protein
(GFAP) using a monoclonal primary antibody conjugated to the ﬂuorescent cyanine
dye Cy3. To reduce background labeling, sections were incubated in sodium boro-
hydride (1% in TBS) for 30 min. After two 15 minwashing steps in TBS, sections were
incubated in 20% normal goat serum (in 0.4% TBS-Triton) at room temperature for
1 h. They were then incubated with the primary antibody (GFAP/Cy3 C9205,
SigmaeAldrich, Vienna, Austria, 1:1000 in 2% normal goat serum and 0.4% TBS-
Triton with 0.1% NaN3) at 4 C in the dark for 72 h. After three washing steps with
TBS (10 min each), the sections were mounted in gelatin-KCr(SO4)2 (Merck, Darm-
stadt, Germany) and cover-slipped using Vectashield mounting medium (Vector
laboratories, Burlingame, USA). The sections were analyzed using a Cy3 ﬁlter-set
(MQ Cy3, F41-007, Zeiss, Vienna, Austria).
2.11. In situ hybridization
Custom-synthesized oligonucleotides (Microsynth, Balgach, Switzerland)
complementary to the mRNAs for the vesicular glutamate transporter VGLUT1 and
for glutamate decarboxylase 65 (GAD65) were used as probes: VGLUT1: 50-GTA GTG
CAG GTG ACT CGT AGG AGA CAA GCA ACC AGA ACA GGT ACC-30 , bases 866e910
(GenBank ID: NM_053859.1; Ni et al., 1994); GAD65: 50-CTC CTT CAC AGG CTG
GCA GCA GGT CTG TTG CGT GGA G-30 , bases 348e384 (GenBank ID: NM_012563.1;
Chang and Gottlieb, 1988). The oligonucleotides (2.5 pmol) were labeled at the 30-
end with [35S] a-thio-dATP (1300 Ci/mmol; New England Nuclear, Boston, USA) by
reaction with terminal deoxynucleotidyltransferase (Roche Austria GmbH, Vienna,
Austria) and in situ hybridization was performed as described previously (Furtinger
et al., 2001). After exposure to BioMax MR ﬁlms for 7 (VGLUT1) or 20 days (GAD65),
sections were dipped at 42 C in photosensitive emulsion (NTB-2, Kodak, Rochester,
USA, diluted 1:1) with distilled water, air dried, and exposed for 10 (VGLUT1) or 30
days (GAD65). Dipped sections and BioMax MR ﬁlms were developed using Kodak
D19 developer (Kodak, Rochester, USA). After counterstaining with cresyl violet,
photoemulsion-dipped sections were dehydrated, cleared in butyl acetate, and
cover-slipped with Eukitt.2.12. Evaluation of neuronal loss and tissue shrinkage
We estimated the extent of neuronal loss in the ventral subiculum, pre- and
parasubiculum, and entorhinal cortex by determining neuron density in NeuN-
labeled sections (three sections per rat). Grayscale images (8 bit) of the para-
hippocampal region were taken at 50-fold magniﬁcation using a Zeiss Axiophot
microscope equipped with a Zeiss AxioCam digital camera (both Zeiss, Vienna,
Austria) and imported into the image processing software ImageJ (ImageJ 1.43c,
National Institutes of Health, USA). A threshold (automatic threshold) was set
resulting in a black and white image. Using the ImageJ tool “Polygon selections”, the
areas of interest were outlined manually and the function “Analyze particles” was
used to measure the total area of the outlined region and the percentage of area that
was occupied by labeled neuronal cell bodies. For each rat, the % areas covered by
cells (area fraction values) of left and right side of the respective parahippocampal
areas of three sections were averaged. We deﬁned and evaluated the following
subregions: The proximal and distal part of the pyramidal cell layer of the sub-
iculum, the principal cell layers of the pre- and parasubiculum, and layers II, III and
VeVI of the medial and lateral EC. To investigate tissue shrinkage in regions with
severe neurodegeneration 3 months after KA injection, photomicrographs of NeuN-
labeled sections at the same anatomical level (2 sections per rat) were taken at 25-
fold magniﬁcation and imported in ImageJ. Subregions of the parahippocampal
region (proximal subiculum, presubiculum, parasubiculum and layer III of the EC)
were outlined manually and the areas of the respective regions were measured.
2.13. Quantiﬁcation of VGLUT1 and of GAD65 mRNA expressing neurons
The numbers of VGLUT1- and GAD65 mRNA expressing neurons were assessed
on bright ﬁeld photomicrographs (200-fold magniﬁcation) of 20 mm thick
photoemulsion-dipped sections after radioactive in situ hybridization. Cell counts
were performed in the pyramidal cell layer of the proximal and distal parts of the
subiculum, and in layer III of the medial and lateral EC. In brief, photomicrographs
were imported into the image processing software ImageJ and a circle with
a diameter of 320 mm (area 80,425 mm2) was placed above the respective cell layers.
Neurons inside the circle expressing VGLUT1- or GAD65 mRNA (displaying silver
grains around the soma) were counted and neuronal density (neurons per area) was
calculated. Values from both hemispheres were averaged.
2.14. Quantiﬁcation of reactive astrocytes and microglia
To quantify the extent of glial activation, reactive microglial cells and astrocytes
were counted in 30 mm sections (2 sections per rat) reacted for Ox-42 or GFAP
immunoreactivities, respectively. Microglial cells and astrocytes were deﬁned as
“reactive” when they presented strongly increased Ox-42- or GFAP-labeling and
altered morphology (e.g. thicker ﬁlopodia) compared to resting microglia or astro-
cytes in controls. Counting was performed using an ocular grid covering an area of
62,500 mm2 at 400-fold magniﬁcation and cell density (cells/mm2) was calculated.
Principal cell layers in the following subregions of the parahippocampal regionwere
investigated: proximal and distal parts of the subiculum, presubiculum, para-
subiculum, layers III and VeVI of the medial and lateral EC, and layers IIeIII of the
perirhinal cortex. Values from both hemispheres were averaged.
2.15. Statistical analyses
Statistical analyses were carried out using the GraphPad Prism 5.0a software for
Macintosh (GraphPad Software, San Diego, CA, USA). For comparison of mean values
of two groups, the Student’s t-test was used. For determining between-group
differences among multiple sets of data compared to controls, ANOVA with Dun-
nett’s multiple comparison post hoc test was used. Linear regression analysis was
performed using GraphPad Prism for investigating relationships between measured
variables. Data are presented as mean  SEM.
3. Results
3.1. Status epilepticus and recurrent seizures increased EEG-activity
Forty-three of 45 transmitter-implanted rats developed SE after
KA injection. Two rats showed stage 2 seizures, 20 rats stage 3
seizures, and 13 rats developed stage 4 seizures. Two rats had no
seizures and 8 rats died during SE. Themean latency to onset of EEG
seizures in rats with rating 3 and 4 was 15.5  1.95 min and that to
the ﬁrst generalized (stage 3) motor seizure 81.1  5.52 min after
KA injection (range 20e145 min). The frequency of generalized
motor seizures during the SE was 6.8  0.79 seizures per hour.
Fig. 1A shows a typical EEG recording covering 20 h after induc-
tion of SE by KA. Injection of diazepam (10e20 mg/kg 120 min after
Fig. 1. Status epilepticus (SE) assessed by telemetric EEG- and video recording. Panel A shows a typical EEG-recording covering 20 h after KA injection (10 mg/kg). Mean latency to
increased EEG activity was 15.5  1.95 min after KA injection, whereas mean latency to behavioral SE was 83  9.1 min. Injections of diazepam (10e20 mg/kg 120 min after ﬁrst
stage 3 seizure) reduced EEG activity but failed to completely stop SE, and increased EEG-activity reappeared again after 4  1.1 h in average and persisted for 22  2.4 h. Panels B to
H show 10 s EEG traces as indicated by arrows in A. Panel B, baseline before KA injection; C, at the onset of subclinical seizures (EEG seizures only); D, at the onset of motor
symptoms of SE (1 h after KA-injection); E, trace during SE (note EEG-spikes at a frequency ofw1.6 Hz); F, reduction of EEG amplitude close to baseline after diazepam injection; G,
EEG activity during the recurrent SE (around 9 h after diazepam and 12 h after KA injection), and H, activity after seizing of the recurrent SE (around 12.5 h after diazepam and 15.5 h
after KA injection). Panel I depicts the development of EEG-spiking during the ﬁrst 20 h after KA injection in two subpopulations of rats that experienced either few (<80; dotted
line) or frequent (>140) and progressive (solid line) spontaneous recurrent seizures during the subsequent three months (see Fig. 2C and D). Note that increased spike frequency
recurred in the group with subsequent progressive seizures.
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Fig. 1F). However, high amplitude EEG activity (without major
motor signs, Fig. 1G) recurred 4  1.1 h after diazepam injection in
all rats with initial rating 3 to 4 and persisted for 22  2.4 h. Spike
numbers assessed by spike counting then reached close to baseline
levels in about 50% of the rats (Fig. 1I). In ﬁve rats high spike
frequency recurred several hrs after diazepam treatment (Fig. 1I).
They showed signiﬁcantly higher numbers of EEG spikes from 3 to
6 h after diazepam injection compared to the remaining 14 rats
(42,638  6161 vs. 24,546  4444 spikes/3 h; P ¼ 0.0445). These
rats with recurrent high spike frequency had clear progression of
spontaneous seizures (Fig. 2D) in contrast to most rats in which
diazepam treatment was more effective (Fig. 2C).
3.2. Manifestation of spontaneous seizures
Telemetric recordings of the EEG and video monitoring were
performed continuously for 3 months. In the two rats with stage 2
SE rating the onsets of spontaneous seizures were 6 and 27 days
after KA injection, respectively, and these rats experienced 12 and 2
spontaneous seizures during the observation period. In rats with
rating 3 to 4 during SE (n ¼ 33), the ﬁrst spontaneous EEG seizures
were detected between 3 and 36 days after KA injection (mean
14.9  1.43 days; Fig. 2A). Fifty percent of these rats had developed
at least one spontaneous seizure after 12 days. In 77% of rats theﬁrst spontaneous EEG seizure was not accompanied by a behavioral
correlate and the ﬁrst spontaneousmotor seizures were detected in
average 21.4  3.62 days after the initial SE. Fifty percent of rats
developed at least one motor (convulsive) seizure during the ﬁrst
17 days (not shown). After the initial spontaneous seizure the rats
showed 1.4 0.44 seizures per day in average (Fig. 2B). In respect to
seizure frequency, the 19 long-term monitored rats could be
separated into two groups: i) rats showing no increase in numbers
of spontaneous seizures (n¼ 14; 0.5 0.08 seizures per day) and ii)
in rats with progressing seizure frequency (n ¼ 5; 4.2  0.90
seizures per day; Fig. 2C and D). The second group had failed to
respond fully to the anticonvulsive diazepam treatment during the
initial SE (see under 3.1. and Fig. 1I). However, there was no
signiﬁcant difference in the latency to the onset of spontaneous
seizures between these two groups (P ¼ 0.9162).
The latency to the onset of spontaneous seizures was also not
different between rats with behavioral seizure rating 3 and those
with rating 4 in the SE (P¼ 0.6886). It also did not correlatewith the
latency to the ﬁrst generalized seizure (stage 3) during SE
(r2¼ 0.00249, P¼ 0.5741). Spontaneous seizures occurredmostly in
clusters and their mean duration was 46  0.6 s. In 90.2% of
spontaneous seizures detected by EEG recordings, also concomitant
motor seizures were seen in the video monitoring. The remaining
9.8% of EEG seizures were not accompanied by motor signs
(subclinical seizures). The majority of spontaneous seizures
Fig. 2. Development of spontaneously recurrent seizures. Panel A depicts the summative occurrence of the ﬁrst spontaneous seizure in rats with initial rating 3 and 4. Three days
after SE the ﬁrst spontaneous EEG seizure was observed in the ﬁrst rat and in 50% of rats after 12 days. After 36 days, all rats (n ¼ 33) showed spontaneous recurrent seizures. In 77%
of rats, the ﬁrst spontaneous seizure was detectable in EEG only and not accompanied by motor signs. Seizures with a behavioral correlate (clinical seizures) in addition to EEG
seizures were detected in average 6.4  1.61 days later. B, Numbers of spontaneous seizures per day in all rats after the ﬁrst spontaneous seizure (n ¼ 19) shown as box plots.
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Fig. 3. Neurodegeneration in the parahippocampal region after KA-induced SE. NeuN-labeling in controls (A) and in rats at different time intervals after KA injection (B, C) revealed
an early onset of widespread neurodegeneration in parahippocampal regions. The proximal subiculum and layer III of the medial EC were the most severely affected regions (arrows
in B and C). Fluoro Jade-C (FJ-C) staining of degenerating neurons in the proximal subiculum (DeG) and layer III of the medial EC (HeK) revealed that massive neurodegeneration
was present already 24 h after the initial SE (E, I). At this interval, FJ-C stained neurons, dendrites, and axons were present in virtually all subregions of the parahippocampal region
and were especially dense in the proximal subiculum (E) and in layer III of the medial EC (I). In both subregions, FJ-C stained neurons were still present one (F and J) and e in 75% of
rats e three months after KA-induced SE (G and K).
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of seizures was evoked by handling the rats, e.g. when changing the
bedding (2.8%). Ten weeks after the initial onset of spontaneous
seizures the total time spent in seizures was 58  14.0 min. No
electrical or behavioral seizures were detected in control rats.
We observed two typical EEG patterns during spontaneous
recurrent seizures in all rats (Fig. 2E and F). Seizure type I (Fig. 2E)
was predominantly detected (69% of all EEG-seizures). It consisted
of a single period of increased EEG activity. Seizure type II consisted
of two phases with increased EEG activity separated by a short
period (<30 s) of low amplitude (Fig. 2F) and accounted for 19% of
all spontaneous seizures. Twelve percent of all spontaneous
seizures were somewhat different and did not clearly ﬁt into these
two categories. Seventy-one percent of seizure type I and 19% of
seizure type II developed during sleep or inactivity. Seizure type II
was most frequently associated with spontaneous seizures without
behavioral correlate (51% of all subclinical seizures) whereas onlySpontaneous seizures occurred in clusters (not shown) and their frequency increased over
progression of subsequent spontaneous seizures (C) and in rats with seizure progression (D)
types (both seizures were spontaneous generalized stage 3 seizures). The respective spectro
shown in panels G to J. Seizure type I (E, G, I) was predominantly (69% of EEG-seizures) detec
II (F, H, J) consisted of two phases of high EEG-amplitude separated by a short phase of low35% of type I seizures were subclinical. If seizure type II was asso-
ciated with behavioral correlates the motor signs generally
occurred during the second phase of increased EEG activity. Typi-
cally, ictal high-amplitude discharges were followed by a post-ictal
EEG depression (Fig. 2E and F).
3.3. Neurodegeneration in parahippocampal regions
3.3.1. Loss in NeuN-positive neurons
We used NeuN labeling to encompass neuronal cell losses and
Fluoro-Jade C (FJ-C) staining for detecting neurons in the process of
degeneration. Neuropathological changes are shown for rats with
seizure rating 3 and 4 during the SE. Changes in stage 2 rats were
similar. Due to the small group size, we did not include them in the
analysis. As shown in Fig. 3AeC and in Table 1, losses of NeuN-
positive neurons were detected throughout parahippocampal
areas. They weremost prominent in layer III of themedial EC (meantime in some rats. Panels C and D illustrate the numbers of seizures in rats without
, respectively. Panels E and F show 150 s of raw EEG traces of the two dominant seizure
grams and power spectra of two representative examples of the same seizure types are
ted in all rats and consisted of a single period of increased EEG amplitude. Seizure type
amplitude and accounted for 19% of all spontaneous seizures.
Table 1
NeuN-ir neurons in parahippocampal regions after KA-induced status epilepticus.
Reduced densities of NeuN-ir neurons indicate rapid neurodegeneration notably in
the proximal subiculum and layer III of the medial EC. Neuronal densities were
assessed on 30 mm thick sections labeled for NeuN-ir. Data are shown as % of controls
(ANOVA with Dunnett’s multiple comparison post hoc test was used for group
comparisons; *P < 0.05; **P < 0.01; ***P < 0.001). Tissue shrinkage was observed in
regionswith severe neurodegeneration 3months after KA injection andmay explain
increases in density of NeuN-ir neurons at that time interval (areas in % of control:
proximal subiculum: 86  2.6%***; distal subiculum: 96  3.6%; presubiculum:











54  5.3% *** 59  7.2% *** 65  5.2% *** 77  3.4% ***
Distal subiculum 85  4.1% ** 94  4.1% 94  2.3% 77  3.2% ***
Presubiculum 90  2.5% 96  1.6% 90  2.2% 77  4.9% ***
Parasubiculum 81  2.1% ** 95  2.7% 85  5.5% ** 80  3.8% ***
Medial EC
Layer II 83  4.3% ** 91  3.5% 86  3.9% ** 78  3.8% ***
Layer III 42  6.4% *** 41  5.5% *** 63  7.6% *** 50  4.8% ***
Layers VeVI 85  3.7% ** 89  3.7% 89  3.5% * 81  3.5% ***
Lateral EC
Layer II 89  4.4% 95  3.8% 87  4.7% 74  4.5% ***
Layer III 77  3.6% * 84  2.8% 85  3.2% 67  5.5% ***
Layers VeVI 82  4.9% * 90  5.2% 88  5.5% 79  3.8% ***
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of the subiculum (mean loss: 37.2  4.26%; Fig. 3B and C; Table 1).
Neurons in the distal part of the subiculum (adjacent to the pre-
subiculum) were less vulnerable (mean loss: 19.9  2.18%; Fig. 3B
and C). Also in the pre- and parasubiculum, only moderate neuro-
degeneration was observed (mean loss of 17.7  2.84% and
19.3  3.04%, respectively; Table 1). In the parasubiculum mainly
the area adjacent to layer II of the EC was affected. Degeneration of
NeuN-positive neurons was maximal or close to maximal already
early after KA injection (24 h after KA-induced SE), indicating the
causal relationship with the initial SE. At the 3-months interval
signiﬁcantly reduced densities of NeuN-positive neurons were
observed in all investigated areas.
In the proximal subiculum, the relative density of NeuN-positive
neurons appeared to recover to some extent after 3 months
(Table 1). There, the area of the pyramidal cell layer was signiﬁ-
cantly smaller than in controls (86  2.6% of controls, P ¼ 0.0008).
This tissue shrinkage was presumably caused by the severe neu-
rodegeneration in this region and by the decreasing gliosis at this
interval after the initial SE. Signiﬁcant tissue shrinkage was also
present in layer III of the EC (88  3.2% of controls, P ¼ 0.017) 3
months after KA injection. In layer III of the EC, however, the
relative density of NeuN-positive neurons did not seem to recover
after 3 months (Table 1). This might point to a greater extent of
ongoing neurodegeneration caused by spontaneous recurrentTable 2
Reduced density of VGLUT1- and GAD65-mRNA expressing neurons in the subiculum and
darkﬁeld photomicrographs of photoemulsion-dipped sections after in situ hybridization
late intervals after KA-induced SE (1 and 3 months) were pooled, respectively. Below the
are shown (ANOVA with Dunnett’s multiple post hoc test; *P < 0.05; **P < 0.01; ***P <
n Proximal Sub
VGLUT1 mRNA
KA, 1e8 days (% of control) 11 56  6.9%***
KA, 1e3 months (% of control) 18 58  4.2%***
Controls (neurons/mm2) 13 848  32.2
GAD65 mRNA
KA, 1e8 days (% of control) 11 64  6.4%***
KA, 1e3 months (% of control) 18 67  3.8%***
Controls (neurons/mm2) 13 114  6.2seizures. Indeed, highest densities of FJ-C stained neurons are
found in layer III of the EC at this time interval (see Fig. 3K).
Loss of NeuN-positive neurons did neither correlate with the
latency (proximal subiculum, r2 ¼ 0.0400, P ¼ 0.5332; distal sub-
iculum, r2 ¼ 0.0188, P ¼ 0.6705; presubiculum, r2 ¼ 0.0097,
P ¼ 0.5332; parasubiculum, r2 ¼ 0.0103, P ¼ 0.7543; medial EC,
layer III, r2 ¼ 0.0432, P ¼ 0.5168) nor with the number of sponta-
neous seizures (proximal subiculum, r2 ¼ 0.0669, P ¼ 0.4169; distal
subiculum, r2 ¼ 0.1016, P ¼ 0.3126; presubiculum, r2 ¼ 0.0464,
P ¼ 0.5014; parasubiculum, r2 ¼ 0.0162, P ¼ 0.6935; medial EC,
layer III, r2 ¼ 0.2162, P ¼ 0.1277) nor with the clinical rating in the
SE (not shown).
3.3.2. Loss in VGLUT1 mRNA containing neurons
For determining the portion of principal neurons degenerating
we estimated the loss of VGLUT1 mRNA containing neurons.
Similar as for NeuN, the extent of neurodegeneration was already
maximal or close to maximal in all investigated subregions 24 h
after the initial SE (Table 2). Also here, the proximal part of the
subiculum (loss by 30e40%) and layer III of the medial EC (mean
loss by 62%) were the most vulnerable areas, while the distal
subiculum (loss by 29% in average) and layer III of the lateral EC
(loss by 26%) were less affected.
3.3.3. Loss in GAD65 mRNA containing neurons
The total number of GAD65 mRNA positive neurons was
considerably lower (up to 90%) than that of VGLUT1 mRNA con-
taining cells. Neurodegeneration was less severe than for principal
neurons. It was strongest in the proximal subiculum (loss by 35%)
and somewhat weaker in the other areas (distal subiculum, medial
and lateral EC, layer III), in average comprising losses by 14e32%
(Table 2).
3.3.4. FluoroJade labeling of degenerating neurons
FJ-C labels neurons that are in the process of neurodegeneration
(Fig. 3DeK). It revealed a pattern largely complementary to NeuN
labeling and VGLUT1 in situ hybridization. In regions with decreased
density of NeuN-positive or VGLUT1 expressing neurons, in partic-
ular in the proximal subiculum and in layer III of the EC (Fig. 3B and
C), we observed numerous FJ-C labeled cells. The numbers of FJ-C
labeled neurons were highest after 24 h (Fig. 3E and I). At later
time intervals, the numbers of FJ-C labeled neurons gradually
declined but residual FJ-C labeled neurons were still present e.g. in
the proximal subiculum (Fig. 3G) andmost notably in layer III of the
EC of 75% of stage 3 and 4 rats after 3 months (Fig. 3K).
3.4. Expression of activated astrocytes
Numerous GFAP-positive astrocytes were present in all layers of
the parahippocampal areas of controls (Fig. 4A). They containedlayer III of the EC. Densities of neurons (number of neurons/mm2) were quantiﬁed in
and expressed as % of controls  SEM. Data for early intervals (24 h and 8 days) and
densities of VGLUT and GAD65-mRNA expressing neurons in the respective controls
0.001).
Distal Sub Medial EC III Lateral EC III
68  6.4%*** 39  8.2%*** 76  2.7%***
74  4.0%*** 38  6.3%*** 72  3.2%***
894  27.2 861  34.3 779  27.7
79  3.1%** 73  4.0%** 73  7.5%*
78  4.5%** 68  3.9%*** 86  3.7%
102  5.9 82  7.6 68  7.4
M. Drexel et al. / Neuropharmacology 63 (2012) 806e817 813long thin processes (Fig. 4F) and were most densely packed in
the alveus, in the outer molecular layer of the subiculum, in the
outer half of layer I of the pre- and parasubiculum and in the
superﬁcial third of layer I of the EC (Fig. 4A). In controls, no
astrocytes with morphological changes typical for activated
astrocytes were detected (residual astrocytes). Reactive astrocytes
with increased GFAP labeling and altered morphology (thickening
of their processes) were detected sporadically already 24 h after
KA injection reaching approximately 13e52 cells/mm2 (Table 3).
At this interval, morphology and labeling intensity of the vastFig. 4. Reactive gliosis after KA-induced SE. Activation of astrocytes (AeJ) occurs slower tha
parahippocampal region of controls (A, F) and 24 h after KA-induced SE (B, G; resting as
(hypertrophic processes) were detected in the subiculum, parasubiculum, entorhinal and p
astrocytes and of reactive microglia was similar at the later intervals. In the subiculum and i
KA-induced SE (E, J). Panels KeT depict changes in Ox-42 (CD11b)-labeled microglia after
hippocampal region of controls (K) and display a highly ramiﬁed morphology (P). Activated
after SE (L, Q). At this interval, activated microglial cells are still evenly distributed in all par
with severe neurodegeneration (M, N, R, S; note the cluster of reactive microglia in the para
subiculum and in layer III of the EC (O, T). Abbreviations: CA1, hippocampal sector CA1; DG
presubiculum; Sub, subiculum.majority of astrocytes was similar as observed in controls (Fig. 4B
and G).
At subsequent intervals (8 d and 1 month after KA-induced SE)
intensely labeled and densely packed reactive astrocytes with
hypertrophic processes were present in virtually all para-
hippocampal areas (Fig. 4C, D, H and I). Highest densities of acti-
vated astrocytes were present in the proximal subiculum
(801  42.8 cells/mm2) and in layers III (777  43.7 cells/mm2) and
VeVI (774  32.0 cells/mm2) of the medial EC. At this interval,
interestingly, reactive astrocytes were more concentrated in layern that of microglia. Astrocytes reveal thin processes and moderate GFAP-labeling in the
trocytes). Activated astrocytes with increased GFAP-labeling and altered morphology
erirhinal cortex 8 days (C, H) and 1 month after SE (D, I). The distribution of activated
n the EC astrocytes with increased GFAP-labeling were still present three months after
KA-induced seizures. Resting microglial cells are almost evenly dispersed in the para-
microglia with altered morphology and intense Ox-42 labeling is present already 24 h
ahippocampal subregions (L). At later intervals reactive microglia accumulates in layers
subiculum; arrow in N) and is still present 3 months after the initial SE in the proximal
, dentate gyrus; EC, entorhinal cortex; PaS, parasubiculum; PRC, perirhinal cortex; PrS,
Table 3
Epilepsy-induced activation of astrocytes in the parahippocampal region. Reactive
astrocytes were identiﬁed by their increased GFAP labeling and altered morphology
(see methods section). They were counted in 30 mm thick sections immune-labeled
for GFAP. Cell densities (number of cells/mm2) are presented as mean  SEM.
Controls (n ¼ 22) revealed no reactive astrocytes. Therefore we did the statistical
comparison versus the 24 h group. Statistical analysis was performed by ANOVA
with Dunnett’s multiple comparison post hoc test for group comparisons (*P < 0.05;
**P < 0.01; ***P < 0.001; animal numbers (n) are given in parenthesis). The highest
cell densities per area are labeled in bold.









Proximal Sub. 48  23.5 801  42.8*** 798  28.8*** 308  40.3***
Distal Sub. 40  16.2 534  53.5*** 460  37.2*** 106  23.8
Presubiculum 13  6.9 115  34.9*** 13  5.4 3  1.6
Parasubiculum 37  14.1 228  32.8*** 245  38.3*** 41  11.9
Medial EC
Layer III 36  11.0 777  43.7*** 640  52.6*** 211  50.7*
Layers VeVI 30  12.6 774  32.0*** 729  36.1*** 213  30.0***
Lateral EC
Layer III 19  9.5 497  38.4*** 322  48.3*** 55  15.5
Layers VeVI 52  21.5 691  39.4*** 614  22.0*** 266  47.1***
Perirhinal cortex 36  10.6 491  39.0*** 326  34.2*** 84  26.1
M. Drexel et al. / Neuropharmacology 63 (2012) 806e817814III of the medial than in the lateral part of the EC (Fig. 4D, Table 3).
With the exception of the presubiculum, one month after SE the
number of activated astrocytes was almost as high as after 8 days
(Table 3 Fig. 4C and D). In the presubiculum it declined. After 3
months the number of GFAP-positive cells became reduced in all
areas, although they were still signiﬁcantly increased in the prox-
imal and distal subiculum, in layers III and VeVI of the medial EC, in
layers VeVI of the lateral EC (Fig. 4E and J, Table 3).
3.5. Expression of reactive microglia
Reactive microgliawas detected using an antibody for the type 3
complement receptor (Ox-42). In controls, faint labeling of micro-
glial cells with thin processes was seen and they were roughly
evenly distributed within the subiculum and the other para-
hippocampal regions (see Fig. 4K and P). Occasionally, single
reactive microglial cells were also detected in controls (not shown)
at densities of 3e8 cells/mm2. The time course of appearance of
reactive microglia after the KA-induced SE was different from that
of proliferating astrocytes. After 24 h, virtually all microglial cells
displayed increased Ox-42 labeling intensity and thicker processes
but were still evenly distributed (Fig. 4L and Q, Table 4). TheirTable 4
Epilepsy-induced activation of microglia in the parahippocampal region. The numbers
immune-labeled for Ox-42 (CD-11b). Data are presented as mean  SEM. Statistical anal
group comparisons (*P < 0.05; **P < 0.01; ***P < 0.001; animal numbers (n) are given in
Region Controls (n¼ 22) KA 24 h (n¼ 9)
Subiculum
Proximal Sub. 8.0  1.49 455  21.2***
Distal Sub. 4.4  1.37 420  16.8***
Presubiculum 2.9  0.84 326  25.4***
Parasubiculum 5.1  1.45 360  20.0***
Medial EC
Layer III 6.2  1.82 438  34.2***
Layers VeVI 7.3  1.66 405  24.4***
Lateral EC
Layer III 5.5  1.78 454  22.9***
Layers VeVI 8.0  1.66 437  25.9***
Perirhinal cortex 6.5  1.36 444  32.2***number increased to about 320e460 cells/mm2 in all
parahippocampal subﬁelds (Table 4).
Eight days after KA injection reactive microglia accumulated in
individual parahippocampal areas (Fig. 4M and R, Table 4), notably
in the pyramidal cell layer (Fig. 4R) and in the inner molecular layer
of the subiculum, in the parasubiculum, in layers I, III, V and VI of
the EC, as well as in the perirhinal cortex (see Fig. 4M). On the other
hand, only few strongly Ox-42 labeled cells were seen in the pre-
subiculum (layers IIeIII) and in layer II of the EC. In layer II of the
parasubiculum, adjacent to the EC, a cluster of reactive microglial
cells was present (Fig. 4M) corresponding to the cell losses in this
area. A few intensely labeledmicroglial cells were found in layer I of
the parasubiculum where degenerating parvalbumin containing
dendrites were observed recently (Drexel et al., 2011).
One month after KA injection, accumulation of reactive micro-
glia was even more pronounced. All layers of the proximal sub-
iculum contained strongly labeled microglial cells (Fig. 4N and S)
reaching 1602  97.3 cells/mm2 (Table 4). In the distal part of the
subiculum Ox-42 positive cells were less numerous and mainly
restricted to the pyramidal cell layer (Fig. 4N, Table 4). Numbers of
reactive microglia did not further increase in the distal subiculum
and the perirhinal cortex and already declined in the presubiculum
where only few cells were strongly Ox-42 immunoreactive (Fig. 4N,
Table 4). A cluster of reactive microglia was located in layer II of the
distal parasubiculum (arrow in Fig. 4N).
Although Ox-42 positive cells were still seen 3 months after KA-
induced SE in many rats, their distribution was more restricted
(Fig. 4O). Intensely labeled cells were present in the pyramidal cell
layer of the proximal subiculum (Fig. 4T), in layers III and VeVI of
the EC, and in the perirhinal cortex (Fig. 4O). In the pre- and par-
asubiculum and in layers I and II of the EC only very few strongly
labeled cells were present in virtually all rats of this interval. In the
presubiculum the highest density of reactive microglia was seen
already 24 h after KA injection (326  25.4 cells/mm2, Table 4).
4. Discussion
In our present study we established video-assisted long-term
telemetric recordings for characterizing the occurrence and
development of spontaneous seizures in freely moving rats after
KA-induced SE, and investigated the time course and regional
presentation of subsequent neurodegeneration and proliferation
of microglia and astrocytes in the subiculum and other para-
hippocampal areas. The main ﬁndings are: 1) the ﬁrst spontaneous
seizure was predominantly detectable only in the EEG and without
behavioral correlate. The latency between SE and presentation ofof reactive microglia (number of cells/mm2) were counted in 30 mm thick sections
ysis was performed by ANOVA with Dunnett’s multiple comparison post hoc test for
parenthesis). The highest cell densities per brain area are labeled in bold.
KA 8d (n¼ 9) KA 1m (n¼ 10) KA 3m (n¼ 14)
1220  66.3*** 1602  97.3*** 407  60.4***
398  38.3*** 406  70.1*** 114  16.3*
100  19.1*** 60  11.5** 33  6.4
276  40.8*** 468  111.4*** 91  12.5
754  69.5*** 1058  142.3*** 278  57.6**
699  55.4*** 946  118.1*** 241  45.3**
593  82.1*** 653  113.9*** 147  37.3
696  55.3*** 983  96.6*** 194  33.8**
589  38.8*** 474  68.1*** 112  24.5*
M. Drexel et al. / Neuropharmacology 63 (2012) 806e817 815the ﬁrst spontaneous seizure was variable ranging from 3 to 36
days. 2) Similarly, the frequency and intensity of subsequent
spontaneous seizures was variable. They did not correlate with the
seizure rating during the preceding SE. 3) Rats, however, with
insufﬁcient anticonvulsant treatment 2 h after onset of the SE
developed more frequent spontaneous seizures than rats with
efﬁcient anticonvulsant interruption of SE. In these rats, the
number of spontaneous seizures was progressing over the 3
months observation period. 4) Spontaneous seizures occurred in
clusters preferentially during sleep and showed different types of
manifestation. 5) The onset of seizure-induced neurodegeneration
was fast and close to maximal already after 24 h. The proximal
subiculum and layer III of themedial ECweremost severely affected.
6) Neurodegeneration was somewhat less severe in GABA neurons
than in principal neurons. 7) Reactive astrocytes and microglia were
detected at the same sites already after 24 h. They became prom-
inent, however, after 8 and 30 days, respectively. 8) Signiﬁcant
neurodegeneration and a cluster of accumulating reactive astrocytes
and microglia were observed in the parasubiculum.
4.1. Status epilepticus and manifestation of spontaneous seizures
Induction of SE by systemic injection of KA was highly repro-
ducible and in agreement with previous studies (Ben-Ari et al.,
1979; Fuller and Olney, 1981; Sperk et al., 1983). The majority of
KA-injected rats (73%) developed an SE exhibiting generalized
seizures of rating 3 or 4. The interruption of SE by diazepam
effectively reduced the mortality (to less than 18%) and the severity
of histopathology without preventing subsequent development of
spontaneous recurrent seizures.
Combined video- and EEG monitoring was valuable for deﬁning
the length of the latent period before the onset of spontaneous
seizures in the freely moving rats and allowed to detect and
discriminate subclinical seizures (without behavioral correlate) and
clinical seizures (with motor seizures detected in video monitoring).
Although almost all rats experienced similarly severe motor seizures
during the SE, the onset of spontaneous seizures was heterogeneous
ranging from 3 to 36 days and did not correlate to behavioral seizure
rating in the SE or with the onset of ﬁrst stage 3 seizures in SE.
Interestingly, using cortical electrodes, also for the pilocarpinemodel
a similar mean latency (7.2 days) with a high variability (range: 5e17
days) was observed (Gofﬁn et al., 2007). In this study, however, only
77% of rats developed spontaneous seizures during an observation
period of 23days. Also in amodel based on hourly systemic injections
of low doses of KA to trigger the SE and recording with chronic elec-
trodes, a similarly long latency (mean: 11days) andbroadrange (7e37
days) of the onset of spontaneous seizures was observed (Williams
et al., 2009). Similar to our study, clustering of spontaneous seizures
was also reported for the pilocarpine and the low-dosing KA model
(Gofﬁn et al., 2007; Grabenstatter et al., 2005; Williams et al., 2009).
In rats showing increased recurrent spike activity 3e6 h after
diazepam treatment subsequent spontaneous seizures were
signiﬁcantly more frequent and progressed. This observation
indicates a direct priming of the late seizures by the recurring
initial SE. The mechanism for this is unclear. It could be due to an
additional kindling effect.
The fact that 80% of the spontaneous seizures were presented
during sleep or inactivity suggests a prominent role of the vigilance
state on brain excitability. It is consistent with observations in other
animal models and in human TLE demonstrating an increased
propensity to generate epileptiform activity during sleep or inac-
tivity (see Dinner, 2002 for review; Hellier and Dudek, 1999).
Two different types of spontaneous seizures were typically
observed: i) one single seizure period or ii) a pair of seizures
interrupted by an about 30 s period of lowamplitude. The relevanceof these apparent differences is not clear. Since we were using
epidural and not depth electrodes we cannot exclude that different
sites of seizure generation may be the cause. Interestingly, in those
seizures where two periods of high amplitude were separated by
a short phase of low amplitude (seizure type II), behavioral corre-
lates were usually only seen during the second period of high
amplitude, indicating generalization of an initial subclinical seizure.
4.2. Neurodegeneration: NeuN-ir and FluoroJade
Neurodegeneration was assessed by the loss of NeuN-positive
and by FJ-C-labeling of degenerating neurons. In addition we
assessed GAD65 and VGLUT1 mRNAs for determining speciﬁc los-
ses in GABA and glutamate neurons, respectively. The most prom-
inent neuronal losses developed in the proximal subiculum and in
layer III of the medial EC (see Du et al., 1995). Although signiﬁcant,
they were less pronounced in the pre- and parasubiculum. Taken
from cell counts of NeuN-positive neurons, neurodegeneration
appeared to be almostmaximal already after 24 h in all investigated
areas (subiculum, parasubiculum, all layers of the EC) except for the
presubiculum. In subregions with the most severe neuro-
degeneration (proximal subiculum, layer III of the medial EC) the
density of surviving neurons, presumably due to tissue shrinkage,
apparently increased again at later intervals (1 and 3 months).
FJ-C labeling, however, was still detectable in 75% of rats after 3
months indicating residual neurodegeneration. A 35% reduction of
neuronal density in the proximal to intermediate subiculum has
been reported in the pilocarpine model of TLE although this study
did not discriminate between changes in the proximal and distal
subiculum (Knopp et al., 2005). Strikingly, the subiculum is almost
entirely preserved in most TLE patients in spite of severe damage of
the hippocampus proper (Furtinger et al., 2001; Thom et al., 2005).
The restriction of neurodegeneration to the proximal subiculum
may be explained by its excitatory innervations originating in layer
III of the EC (temporo-ammonic path). Whereas the medial EC
(layer III) projects mainly to the distal subiculum, projections of the
lateral EC primarily innervate the proximal subiculum. Thus the
rapid loss of layer III pyramidal neurons in the medial EC may
protect the respective target neurons in the distal subiculum due to
a loss in excitatory drive.
In the EC, high vulnerability of neurons in layer III of the medial
EC have beenwell documented already 24 h after inducing SE by KA
(Du et al., 1995), pilocarpine (Kobayashi et al., 2003; Wozny et al.,
2005a), lithium-pilocarpine (Du et al., 1995) or electrical stimula-
tion (Du et al., 1995; van Vliet et al., 2004). Our study revealed
neuronal losses ranging from37% to 59% in layer III of themedial EC.
The extent of neurodegeneration was similar between rats killed
either 24hor 8 days afterKA-induced SE. At later intervals, however,
neuronal densities even seemed to recover somewhat, which is
probably attributable to theobserved tissue shrinkage. This suggests
that the observedneurodegeneration ismainly a consequence of the
initial SE and not of the subsequent spontaneous seizures. On the
other hand, FJ-C labeling at the late intervals indicates neurode-
generative processes ongoing even 3 months after the initial SE.
The high vulnerability of layer III neurons in the medial EC may
be related to its connectivity. The medial, but not the lateral part of
layer III of the EC receives a speciﬁc and dense,mostly glutamatergic
projection from principal neurons of the presubiculum (Caballero-
Bleda and Witter, 1993; Wouterlood et al., 2004). These neurons
largely survive the initial SE. Thus, seizure-induced over-excitation
of principal neurons in the presubiculum may signiﬁcantly
contribute to the neuronal death at their target site in layer III of the
medial EC (Eid et al., 1996). Indeed, lesion of the presubiculum by
ibotenic acid injection partially protected neurons in layer III of the
EC from KA-induced neurodegeneration (Eid et al., 2001).
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Due to different ﬁxation procedures required, the loss in NeuN-
ir neurons and that in VGLUT1 and GAD65 mRNA positive neurons
was examined in different groups of animals. Never the less, there
is a good correlation between the general loss of neurons labeled
for NeuN and those labeled for the markers of GABA and glutamate
neurons, respectively. Taken the three months interval, loss of
VGLUT1 mRNA containing neurons exceeds that of NeuN-positive
cells in the proximal but not in the distal subiculum and in layer III
of the medial but not of the lateral EC. In contrast, GAD65 mRNA
expressing neurons are, except for the lateral EC, less vulnerable
than the whole neuronal population labeled for NeuN. Accordingly
losses in VGLUT1 mRNA containing neurons are somewhat higher
than those of GAD65 mRNA containing neurons. Only in the medial
EC losses in VGLUT1 mRNA containing neurons almost double
those of GAD65mRNA containing cells. In general this may indicate
that principal neurons are more densely innervated by excitatory
projections than interneurons in these areas. Since GAD67 and
GAD65 are generally expressed together (Soghomonian andMartin,
1998) GAD65 mRNA labels all GABA neurons. Subpopulations of
these may differ in vulnerability to seizure-induced damage. Thus,
losses in parvalbumin containing neurons are more severe than
those in GAD65 mRNA containing ones (Drexel et al., 2011). In the
lateral EC layer III the number of GAD65 mRNA positive neurons
appeared to recover somewhat (statistically not signiﬁcant) at the
1e3 months interval. Explanations may be tissue shrinkage or
better detection due to upregulation of GAD65 mRNA in surviving
GABA neurons. Also proliferation of neurons may be considered
although this seems to be mainly restricted to the dentate gyrus
and the olfactory pathway (Parent, 2007).
4.4. Reactive gliosis: a chronic inﬂammatory state in the subiculum
and EC
Activated astrocytes and reactive microglia, characterized by
increased expression of GFAP and Ox-42, respectively, were already
present 24 h after KA-induced SE. General activation of astrocytes
became manifest after 24 h and further markedly increased after 8
days and 1 month (being somewhat higher after 8 days in most
areas). After 3 months it became signiﬁcantly reduced but was still
present in most areas. Presentation of reactive microglia was
somewhat different. After 24 h about 10 times more reactive
microglial cells than activated astrocytes were present. Their
number increased after 8 days, but in most areas reached its
maximum only after 1 month (except for the presubiculum, distal
subiculum and perirhinal cortex) and reactive microglia was still
present in the subiculum and EC after 3 months.
Development of spontaneous seizures took place between 3 and
36 days after the initial status epilepticus. Although residual neu-
rodegeneration was still seen at late intervals tissue damage was
mainly concluded prior to the ﬁrst spontaneous seizures observed.
Reactive astrocytes andmicrogliawere expressed during the period
of upcoming initial spontaneous seizures. Their pattern and time
course of presentation may indicate that they develop as a conse-
quence of neurodegeneration. Interestingly numbers of astrocytes
initially activated at the 24 h interval were low and their distribu-
tionmore or less equal in all parahippocampal areas, presumably as
a consequence of the generalized seizures. Thereafter activated
microglia and astrocytes follow the pattern of neurodegeneration
and presumably most severe excitatory activity. Although the time
course of activation was somewhat different, the regional distri-
bution patterns of reactive microglia and astrocytes were similar.
Areas with highest neurodegeneration, such as the proximal sub-
iculum and layer III of the medial EC showed also highest numbersof reactive astrocytes and microglia indicating a relationship
between neurodegeneration and glia proliferation. Both events
may be driven by excitatory activity within the respective circuit-
ries during the initial SE or by subsequent spontaneous seizures.
They may, however, be also critically involved in the development
of spontaneous seizures.
Recent studies revealed an important role of inﬂammatory
processes in the manifestation of seizures. Pro-inﬂammatory cyto-
kines such as interleukin1-b (IL-1b) or tumor necrosis factor a (TNF-
a), presumably released from activated astrocytes and microglia
increase network excitability (Akassoglou et al., 1997; Campbell
et al., 1993; De Simoni et al., 2000; Vezzani et al., 1999a). Further-
more, activated astrocytes likely contribute to increased extracel-
lular glutamate levels seen in epileptic foci (see Glass and
Dragunow, 1995 for review) either by increased release of gluta-
mate (Angulo et al., 2004; Jabs et al., 2008) or by reduced uptake of
extracellular glutamate via the astrocytic glutamate transporter
GLT-1 (Mathern et al., 1999; Rothstein et al., 1996; Tanaka et al.,
1997) although Takahashi et al. (2010) did not detect a change in
GLT-1 expression 7 days after KA-induced SE. Furthermore,
impaired Kþ buffering caused by a reduced expression of Kir chan-
nels in astrocytes has been implicated in enhanced seizure
susceptibility of sclerotic hippocampal tissue (Seifert et al., 2010).
Thus, the persisting state of glial proliferation in the proximal
subiculum and in the EC may contribute to the increased excit-
ability of these regions reported in the recent years (Cohen et al.,
2002; de Guzman et al., 2008; Knopp et al., 2005; Kobayashi
et al., 2003) and may have a role in the generation and manifes-
tation of spontaneous recurrent seizures.
5. Conclusions
In conclusion, video-assisted telemetric EEG recording is a valid
tool for monitoring subclinical and clinical seizures in freely
moving rats. The latency of onset of spontaneous seizures after KA-
induced SE is similar as that seen in other animal models of TLE and
using depth electrodes for EEG monitoring. KA-induced seizures
cause a widespread but speciﬁc pattern of neurodegeneration in
parahippocampal areas that is mostly followed by astrocytic and
microglia proliferation in the same areas. The time course of glial
proliferation, but not that of neurodegeneration, correlateswith the
time range of onset of spontaneous seizures, supporting a rela-
tionship of astrocyte and microglia proliferation in epileptogenesis.
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